The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Osteoporosis Foundation (IOF) have awarded the ESCEO-IOF Pierre Meunier Young Scientist Award to Dr Nicola Veronese of the University of Palermo. The Award was presented on August 27th at a special session of the virtual WCO-IOF-ESCEO 2021, the largest global Congress in the bone, muscle and joint field.

Presented annually, the ESCEO-IOF Pierre Meunier Young Scientist Award recognizes young investigators who have demonstrated outstanding scientific merit early in their careers, prior to reaching a prominent academic position, and who are expected to be future thought-leaders in the musculoskeletal field. 

Professor Jean-Yves Reginster, ESCEO President and Congress Co-Chair noted:

“It is a great pleasure to present this prestigious award to such an outstanding young investigator. Early in his career, Dr Veronese has made important contributions to research in the epidemiology of frailty, osteoarthritis and related geriatric disorders and chronic conditions. He is a highly valued member of the ESCEO Scientific Advisory Board, and we look forward to his many future research contributions to the geriatric and musculoskeletal fields.”

Dr Nicola Veronese, MD, is Assistant Professor and Senior Researcher at the University of Palermo, Health Promotion, Maternal and Child Health, and Internal Medicine and Specialty of Excellence "G. D'Alessandro". After obtaining his medical degree in 2008, Dr Veronese attended the School of Geriatric Medicine. He is the author of more than 450 articles, primarily on the epidemiology of musculoskeletal diseases in older adults, which have been published in international, peer-reviewed journals. He is on the ESCEO Scientific Advisory Board and is a member/director of  scientific committees of several national and international societies in the field of geriatric medicine.


About the World Congress on Osteoporosis, Osteoarthritis & Musculoskeletal Diseases (WCO-IOF-ESCEO)
Held jointly by IOF and ESCEO, the WCO-IOF-ESCEO annual congress is the world’s largest forum for the presentation of clinical research and new advances in the prevention and management of musculoskeletal disorders, including sarcopenia and frailty. WCO-IOF-ESCEO 2021 will be held as a virtual congress from August 26 to 28, 2021, with access on demand for registrants up to three months following the congress. For complete information visit  #OsteoCongress

The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) is a non-profit organization, dedicated to a close interaction between clinical scientists dealing with rheumatic disorders, pharmaceutical industry developing new compounds in this field, regulators responsible for the registration of such drugs and health policy makers, to integrate the management of osteoporosis and osteoarthritis within the comprehensive perspective of health resources utilization. The objective of ESCEO is to provide practitioners with the latest clinical and economic information, allowing them to organize their daily practice, in an evidence-based medicine perspective, with a cost-conscious perception.   

About IOF
The International Osteoporosis Foundation (IOF) is the world's largest nongovernmental organization dedicated to the prevention, diagnosis and treatment of osteoporosis and related musculoskeletal diseases. IOF members, including committees of scientific researchers as well as 268 patient, medical and research societies, work together to make fracture prevention and healthy mobility a worldwide heath care priority.  @iofbonehealth